Recent Finacing
Recent Raise
ARS Pharmaceuticals develops Neffy (ARS‑1), an intranasal epinephrine spray using absorption technology for treatment of severe allergic reactions, pursuing regulatory approval, clinical studies, and initial commercialization.
